Company to Take Part in Fireside Chat
Wednesday, January 18, 2023 at
7:00am PST/10:00am EST
SUNNYVALE, Calif., Jan. 10,
2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ:
ARAY) announced today its participation in the B. Riley Securities'
3rd Annual Oncology Conference taking place January 18-19, 2023. The management team is
scheduled to participate in a virtual Fireside Chat on Wednesday, January 18, 2023 at 7:00am PST/10:00am
EST.
A live webcast of the Fireside Chat can be accessed on the
Accuray website at investors.accuray.com. A replay will be
available on the Company's website following the event.
B. Riley Securities 3rd Annual Oncology Conference, January 18-19, will feature over 30 SMiD cap
healthcare companies focused on the development and
commercialization of new medicines and key enabling technologies,
cutting across multiple next-generation therapeutic modalities. The
conference will feature KOL panel discussions with academic and
industry leaders at the forefront of translational and clinical
research underway with novel immunotherapy, cell therapy, and
targeted oncology approaches, as well as imaging and radiation
oncology initiatives, aimed at driving meaningful improvements to
current standard of care for cancer patients.
About Accuray
Accuray Incorporated is committed to expanding the powerful
potential of radiation therapy to improve as many lives as
possible. We invent unique, market-changing solutions that are
designed to deliver radiation treatments for even the most complex
cases—while making commonly treatable cases even easier—to meet the
full spectrum of patient needs. We are dedicated to continuous
innovation in radiation therapy for oncology, neuro-radiosurgery,
and beyond, as we partner with clinicians and administrators,
empowering them to help patients get back to their lives, faster.
Accuray is headquartered in Sunnyvale,
California, with facilities worldwide.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-to-participate-in-the-b-riley-securities-3rd-annual-oncology-conference-301718314.html
SOURCE Accuray Incorporated